Company: NIVFW
Filing Date: 2025-03-07
Form Type: F-1
Source: 0001213900-25-021404
Chunk: 110

Company: NewGenIvf Group Ltd
Filing Date: 2025-03-07
Form: F-1
Chunk 110
---
 (i) adjustments for depreciation and amortization of US$303,944, (ii) changes in contract liabilities of US$548,010 and (iii) changes in directors’ remuneration of US$240,000, partially offset by operating lease liabilities of US$175,132. Investing activities Net cash used in investing activities in the nine month period ending on September 30, 2024 was ($66,718), primarily representing NewGenIvf’s additional equipment and improvement at its Thailand clinic. Net cash used in investing activities in 2023 was US$69,848, primarily representing purchase of plant and equipment. Net cash used in investing activities in 2022 was US$94,452, primarily representing purchase of plant and equipment. Financing activities Net cash used provided by financing activities in the nine month period ending on September 30, 2024 was 2,785,527, primarily representing a debt financing by convertible promissory notes. Net cash provided by financing activities in 2023 was US$1,881,493, primarily representing amounts from shareholders. Net cash used in financing activities in 2022 was US$1,633,781, primarily representing amounts due from related parties. Contractual Obligations The following table sets forth NewGenIvf’s main contractual obligations and commitments as of December 31, 2023.

|                                     |     | December 31, |         |     |      |         |
|                                     |     |         2023 |         |     | 2022 |         |
|                                     |     |          US$ |         |     |  US$ |         |
| Lease liabilities – current portion |     |              | 207,128 |     |      | 184,651 |
| Lease liabilities – non-current     
 portion                             |     |              | 118,979 |     |      | 242,187 |
| Total                               |     |              | 326,107 |     |      | 426,838 |

Off-Balance Sheet Commitments and Arrangements NewGenIvf has not entered into any financial guarantees or other commitments to guarantee the payment obligations of any third parties, nor any derivative contracts that are indexed to its shares and classified as shareholder’s equity or that are not reflected in its consolidated financial statements. Furthermore, NewGenIvf does not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. NewGen